SCHEMBL7706329

SCHEMBL7706329

Cc1ccccc1NC1(C(N)=O)CCN(Cc2ccccc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.65
CYP2D6 P10635 2/20 0.65
TSHR P16473 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.50
RECQL P46063 1/20 0.50
NPFFR1 Q9GZQ6 4/20 0.49
NPFFR2 Q9Y5X5 4/20 0.49
OPRK1 P41145 2/20 0.49
OPRM1 P35372 1/20 0.49
OPRD1 P41143 1/20 0.49
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA4 P22748 1/20 0.45
CA5A P35218 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20187025 0.85 ALDH1A1 (0.61) ALDH1A1CYP2D6TSHRNPFFR1NPFFR2
SCHEMBL28105514 0.85 CYP2D6 (0.61) ALDH1A1CYP2D6TSHRNPFFR1NPFFR2
SCHEMBL2996293 0.83 CYP2D6 (0.68) ALDH1A1CYP2D6TSHRNPFFR1NPFFR2
SCHEMBL3210066 0.83 CYP2D6 (0.76) ALDH1A1CYP2D6TSHRNPFFR1NPFFR2
SCHEMBL3939085 0.83 CYP2D6 (0.65) ALDH1A1CYP2D6TSHRSMN1; SMN2NPFFR1
SCHEMBL16876740 0.81 CYP2D6 (0.60) ALDH1A1CYP2D6TSHRNPFFR1NPFFR2
SCHEMBL7707050 0.80 ALDH1A1 (0.61) ALDH1A1CYP2D6TSHRSMN1; SMN2NPFFR1
SCHEMBL16876743 0.80 CYP2D6 (0.57) ALDH1A1CYP2D6TSHRNPFFR1NPFFR2
SCHEMBL971337 0.80 CYP2D6 (0.70) ALDH1A1CYP2D6TSHRNPFFR1NPFFR2
SCHEMBL15026729 0.79 SMN1; SMN2 (0.53) ALDH1A1CYP2D6TSHRSMN1; SMN2RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921125-B1 1,3,8-Triazaspiro[4,5]decan-4-on derivatives HOFFMANN LA ROCHE (CH) 2002-01-30 EP disclosed
US-6043366-A USEFUL IN TREATING DISORDERS INVOLVING THE ORPHANIN FQ(A SEVENTEEN AMINO ACID LONG PEPTIDE) RECEPTOR. HOFFMAN-LA ROCHE INC. (US) 2000-03-28 US disclosed
EP-0921125-A1 1,3,8-Triaza-spiro 4,5 decan-4-on derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-06-09 EP disclosed